Treatment of abnormal cholesterol levels in the blood with Unani medicine
Phase 2
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2023/07/055320
- Lead Sponsor
- uqman Unani Medical college hospital and research centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants of any gender.
-Age between 20 and 60 years.
-Participants with serum cholesterol more than or equal to 200mg per dL, serum triglycerides(TG) more than or equal to 150mg per dL, Low Density Lipoprotein cholesterol (LDL) more than or equal to 130mg per dL, High Density Lipoprotein (HDL) less than or equal to 40 mg per dL.
Exclusion Criteria
-Participants with comorbidities such as IHD, hypertension, diabetes, chronic kidney disease, malignancy, and other aggravating conditions.
-Pregnant & lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the levels of: <br/ ><br>LDL-C <br/ ><br>HDL-CTimepoint: At baseline and 3 months.
- Secondary Outcome Measures
Name Time Method Changes in the levels of: <br/ ><br>Total cholesterol, <br/ ><br>Triglycerides, <br/ ><br>Non-HDL-C, <br/ ><br>Very Low Density Lipoprotein VLDL, <br/ ><br>Total Cholesterol HDL Cholesterol Ratio, <br/ ><br>FBS, <br/ ><br>SGOT, <br/ ><br>SGPT, <br/ ><br>ALP, <br/ ><br>Serum Creatinine, & <br/ ><br>Blood Urea NitrogenTimepoint: At baseline & 3 months.